Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models

Area of Science:

• Computational chemistry
• Medicinal chemistry
• Artificial intelligence in drug discovery

Background:

• De novo drug design aims for efficient, cost-effective generation of novel chemical compounds.
• Deep generative models are emerging as powerful tools for molecular structure generation.
• Most current models focus on 2D molecular structures, limiting direct 3D application.

Purpose of the Study:

• To review recent advancements in 3D molecular generative models.
• To discuss the integration of deep learning with 3D molecule generation.
• To explore future directions for de novo drug design using 3D models.

Main Methods:

• Review of literature on deep learning-based generative models for molecular design.
• Analysis of architectures and optimization strategies for 3D molecule generation.
• Discussion of target-conditioning approaches in 3D drug design.

Main Results:

• Significant progress has been made in developing 3D molecular generative models.
• These models offer unique advantages over 2D models for drug design.
• 3D models show potential for direct, target-specific drug-like molecule generation.

Conclusions:

• Deep learning-powered 3D generative models represent a promising frontier in de novo drug design.
• Further research is needed to fully realize the potential of these models for efficient and targeted drug discovery.
• The review provides insights into current developments and future prospects in the field.